OCGN (STOCKS)
Ocugen, Inc. Common Stock
$1.340000
-0.060000 (-4.29%)
Prev close: $1.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shankar Musunuri
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $510.84M
- Employees
- 95
- P/E (TTM)
- -5.50
- P/B (TTM)
- -28.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.07 | $-0.05 | -0.0156 | -28.68% |
|
Mar 2026 (Q1)
|
$-0.06 | $-0.05 | -0.0075 | -14.29% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.06 | -0.0008 | -1.35% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.06 | -0.0129 | -22.59% |
Financial Statements
| Revenues | $4.58M |
| Benefits Costs and Expenses | $72.26M |
| Costs And Expenses | $78.41M |
| Nonoperating Income/Loss | -$12.91M |
| Operating Expenses | $73.48M |
| Research and Development | $43.76M |
| Other Operating Expenses | $29.72M |
| Operating Income/Loss | -$68.90M |
| Income/Loss From Continuing Operations After Tax | -$81.81M |
| Income/Loss From Continuing Operations Before Tax | -$88.39M |
| Net Income/Loss | -$81.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$81.81M |
| Net Income/Loss Available To Common Stockholders, Basic | -$81.81M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $124.21M |
| Current Assets | $106.72M |
| Noncurrent Assets | $17.49M |
| Fixed Assets | $13.35M |
| Other Non-current Assets | $4.14M |
| Liabilities | $140.76M |
| Current Liabilities | $133.08M |
| Accounts Payable | $5.14M |
| Wages | $2.53M |
| Other Current Liabilities | $125.41M |
| Noncurrent Liabilities | $7.68M |
| Equity | -$16.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$16.56M |
| Liabilities And Equity | $124.21M |
| Net Cash Flow From Operating Activities | -$60.87M |
| Net Cash Flow From Operating Activities, Continuing | -$60.87M |
| Net Cash Flow From Investing Activities | -$148.00K |
| Net Cash Flow From Investing Activities, Continuing | -$148.00K |
| Net Cash Flow From Financing Activities | $133.86M |
| Net Cash Flow From Financing Activities, Continuing | $133.86M |
| Exchange Gains/Losses | $200.00K |
| Net Cash Flow | $73.05M |
| Net Cash Flow, Continuing | $72.85M |
| Comprehensive Income/Loss | -$81.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$81.82M |
| Other Comprehensive Income/Loss | $50.34M |